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Auditory hallucinations: Does a continuum of severity entail continuity in 
mechanism?  
The continuum view holds that psychotic symptoms vary along dimensions such as distress, vividness 
and duration in clinical and non-clinical groups.  At one extreme, symptoms are so severe and disabling 
that they require treatment and sometimes hospitalisation.  At the other end of the spectrum, 
individuals display similar symptoms without significant distress, disability or dysfunction. 
Recently, the continuum model has come under pressure from different directions1.  Its postulation 
of gradual quantitative transitions across a continuum of symptom expression lends itself well to 
empirical evaluation.  In support of the model, research efforts have identified similarities in psychosis-
like experiences between healthy and psychiatric groups, from which common underlying mechanisms 
are sometimes inferred.  This search for commonality might follow from an assumption that different 
levels of explanation map neatly onto each other.  While similarities between groups in features of 
symptom expression might align with commonalities at the neurobiological level, they equally may not.  
Complex systems lend themselves to analysis at multiple levels of organisation, and we should be wary 
of inferring from a continuum at one level that there must also be a continuum at another. 
A case in point is the example of auditory hallucinations.  There are few discernible differences in 
the descriptive features of experience between psychotic and non-psychotic hallucinations2.   Some non-
clinical voice-hearers report vivid and frequent hallucinations, third-person hallucinations, and 
personification, as well as some negative contents, resembling the hallucinations of people diagnosed 
with a psychotic disorder.  In the absence of differential phenomenological markers, a common 
approach in making diagnostic and treatment decisions is to focus on the presence of distress, or 
impairments in social, occupational or other important areas of functioning, as a threshold for clinically 
significant symptoms3.  An over-emphasis on distress and functioning, however, may obscure important 
continuities and discontinuities across different population groups.  
One example includes evidence of categorical differences within people presenting with psychosis-
like experiences in the general population.  At least two different continua have been proposed: a 
continuum of symptom expression, distributed across clinical and non-clinical groups, and a 
(dis)continuum of risk whereby only a subset of individuals are vulnerable to developing psychosis4,5.  
Even with a continuum of symptom expression, it seems likely that important discontinuities will exist.  
Studies are now investigating distinct non-clinical subgroups such as professional psychics, voice-hearers 
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with no psychiatric diagnosis, people at high risk or in the prodrome phase of psychosis, as well as 
individuals who score highly on measures of psychosis proneness.  The extent to which these form a 
heterogeneous group within the category of non-clinical hallucinations is still unclear, and future 
research will be helpful in determining whether such groups differ on variables relating to aetiology, 
phenomenology, subjective appraisals, and underlying mechanisms. 
Neurobiological studies also reveal a complex pattern of continuity and discontinuity between 
pathological and nonpathological experiences.  First, results of imaging studies show that brain changes 
in people with medical conditions who have hallucinations (acquired deafness, narcolepsy, etc.) are 
localised and specific6,7, which contrasts with the widespread changes observed in hallucinating 
individuals with schizophrenia8.   Second, studies of neurobiological processes involving direct 
comparisons of clinical and non-clinical samples show similarities as well as important differences.  A 
functional Magnetic Resonance Imaging (fMRI) study comparing a healthy and psychiatric group with 
frequent hallucinations revealed continuity in activation of the superior temporal gyrus and bilateral 
inferior frontal gyri9, while a structural MRI study showed comparable changes in the insular region10.   
Other evidence involving direct group comparisons points to discontinuity in mechanisms.  Garrison 
et al (this issue11) examined the structure of the paracingulate sulcus (PCS), a region in the anterior 
medial prefrontal cortex implicated in reality monitoring.  Structural MRI scans revealed shorter PCS 
length in the psychotic group with frequent hallucinations, which differentiated them from the non-
psychiatric comparison groups (with and without hallucinations).  
A limitation of all three studies (each conducted with the same large non-clinical sample from the 
Netherlands) is the absence of a psychosis comparison group without hallucinations, without which 
specificity to hallucinations and the contribution of other symptom mechanisms cannot be assessed.  
Nonetheless, the finding of typical PCS lengths in the non-clinical group with hallucinations is in line with 
a recent cognitive study which failed to find reality-monitoring deficits in non-clinical individuals scoring 
high on measures of hallucination proneness12.  In further support for discontinuity in process, the 
cognitive literature in non-clinical samples with hallucinations shows largely mixed results5,12, although 
traditional difficulties in publishing negative findings likely act to bias the literature.   
Further evidence of discontinuity in mechanisms includes pharmacological evidence that striatal 
dopaminergic overactivity may be specific to symptoms in psychosis.  Positron Emission Tomography 
(PET) imaging studies suggest that elevated striatal dopamine production (which characterizes 
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psychosis) is not a feature of non-clinical groups with hallucinations13. Another interpretation of this 
finding is that hallucinations should not be considered a core feature of psychosis (or at least not as 
central a feature as striatal dopamine dysregulation), since they occur in both psychotic and non-
psychotic groups, as well as other psychiatric and medical conditions with distinct underlying 
mechanisms.  In support, classical texts refer to hallucinations as secondary (non-integral) feature of 
schizophrenia14. In any case, since antipsychotic medication seems only to benefit patients with 
increased striatal dopamine15, a clinical implication of this finding is a caution about the introduction of 
antipsychotic medication until alternative medical causes for distressing hallucinations have been 
excluded. 
An emerging theme from this recent literature is that there may be a mix of continuity and 
discontinuity in hallucination-related processes across the spectrum from wellness to disorder.  One 
candidate for a continuous process is alteration in spontaneous auditory cortex activation, which may 
feature in both clinical and non-clinical hallucinations11.  By contrast, candidates for discontinuous 
mechanisms include prefrontal reality-monitoring processes and striatal dopaminergic dysregulation, 
which appear more specific to hallucinations in psychosis.  These points of difference might explain 
intact reality-monitoring and preserved insight in the non-clinical groups.    
Further research into the neural and psychological processes underlying non-clinical hallucinations 
will likely clarify this picture.  Methodologically robust designs should include appropriate psychiatric 
and non-psychiatric comparison groups, and a greater focus on potential differences between groups in 
medication, lifestyle and clinical risk factors. Greater attention should also be paid to co-occurring 
experiences (e.g., delusional thinking, negative symptoms) which are often neglected in non-clinical 
groups.  
In conclusion, there are dangers in inferring continuity in mechanism from continuity in 
phenomenology, including a risk of incorrect treatment.  On the other hand, discontinuity of mechanism 
between clinical and non-clinical groups presents opportunities for research.  These include the 
development of sensitive measures to chart heterogeneity across the clinical divide and enhance the 
detection of individuals at risk of psychosis.  Another challenge is to understand the therapeutic needs 
of people with different hallucination subtypes so that individuals can access support depending on 
symptom-specific needs. In the meantime, a graded approach to intervention (holding in mind the 
possibility of phenomenological continuity) is desirable, as is recognition of possible discontinuity in 
underlying mechanisms, with interventions tailored accordingly16.   
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